159 related articles for article (PubMed ID: 22476400)
1. Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesions.
Yoshida M; Tsuda H; Yamamoto S; Kinoshita T; Akashi-Tanaka S; Hojo T; Fukutomi T
Virchows Arch; 2012 May; 460(5):497-504. PubMed ID: 22476400
[TBL] [Abstract][Full Text] [Related]
2. Papillary lesions of the breast: a molecular progression?
Di Cristofano C; Mrad K; Zavaglia K; Bertacca G; Aretini P; Cipollini G; Bevilacqua G; Ben Romdhane K; Cavazzana A
Breast Cancer Res Treat; 2005 Mar; 90(1):71-6. PubMed ID: 15770529
[TBL] [Abstract][Full Text] [Related]
3. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
[TBL] [Abstract][Full Text] [Related]
4. Different incidence of loss of heterozygosity on chromosome 16q between intraductal papilloma and intracystic papillary carcinoma of the breast.
Tsuda H; Uei Y; Fukutomi T; Hirohashi S
Jpn J Cancer Res; 1994 Oct; 85(10):992-6. PubMed ID: 7961109
[TBL] [Abstract][Full Text] [Related]
5. LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast.
Lininger RA; Park WS; Man YG; Pham T; MacGrogan G; Zhuang Z; Tavassoli FA
Hum Pathol; 1998 Oct; 29(10):1113-8. PubMed ID: 9781650
[TBL] [Abstract][Full Text] [Related]
6. [Differential diagnosis of intracystic papillary tumors of the breast by examination of loss of heterozygosity on chromosome 16q].
Tsuda H
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():52-8. PubMed ID: 7747993
[TBL] [Abstract][Full Text] [Related]
7. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
8. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q.
Tsuda H; Hirohashi S
Cancer Res; 1995 Aug; 55(15):3395-8. PubMed ID: 7614478
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.
Driouch K; Dorion-Bonnet F; Briffod M; Champéme MH; Longy M; Lidereau R
Genes Chromosomes Cancer; 1997 Jul; 19(3):185-91. PubMed ID: 9219000
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of breast papillary lesion on core needle biopsy: experience in African-American population.
Wang H; Tsang P; D'Cruz C; Clarke K
Diagn Pathol; 2014 Apr; 9():86. PubMed ID: 24762090
[TBL] [Abstract][Full Text] [Related]
11. Intraductal papillary lesions of the breast: clinical and pathological correlation.
Shouhed D; Amersi FF; Spurrier R; Dang C; Astvatsaturyan K; Bose S; Phillips E
Am Surg; 2012 Oct; 78(10):1161-5. PubMed ID: 23025963
[TBL] [Abstract][Full Text] [Related]
12. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
13. Ultrasonography-guided core needle biopsy in differential diagnosis of papillary breast tumors.
Bode MK; Rissanen T; Apaja-Sarkkinen M
Acta Radiol; 2009 Sep; 50(7):722-9. PubMed ID: 19488890
[TBL] [Abstract][Full Text] [Related]
14. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
Carder PJ; Garvican J; Haigh I; Liston JC
Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
[TBL] [Abstract][Full Text] [Related]
15. Significance of papillary lesions at percutaneous breast biopsy.
Valdes EK; Tartter PI; Genelus-Dominique E; Guilbaud DA; Rosenbaum-Smith S; Estabrook A
Ann Surg Oncol; 2006 Apr; 13(4):480-2. PubMed ID: 16474908
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
17. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
Tsuda H; Fukutomi T; Hirohashi S
Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981
[TBL] [Abstract][Full Text] [Related]
18. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
[TBL] [Abstract][Full Text] [Related]
19. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features.
Shiino S; Tsuda H; Yoshida M; Jimbo K; Asaga S; Hojo T; Kinoshita T
Pathol Int; 2015 Jun; 65(6):293-300. PubMed ID: 25801805
[TBL] [Abstract][Full Text] [Related]
20. Papillary lesions of the breast: imaging findings and diagnostic challenges.
Jagmohan P; Pool FJ; Putti TC; Wong J
Diagn Interv Radiol; 2013; 19(6):471-8. PubMed ID: 23996839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
